Latest Insider Transactions at Centene Corp (CNC)
This section provides a real-time view of insider transactions for Centene Corp (CNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CENTENE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CENTENE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
2,000
-17.67%
|
-
|
|
Feb 28
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,082
+15.54%
|
$990,756
$58.54 P/Share
|
|
Feb 26
2021
|
Robert K Ditmore Director |
BUY
Open market or private purchase
|
Indirect |
170
+0.3%
|
$9,860
$58.45 P/Share
|
|
Feb 11
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
7,875
+28.37%
|
-
|
|
Feb 11
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
7,875
-5.5%
|
-
|
|
Feb 11
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
8,000
-5.63%
|
$480,000
$60.97 P/Share
|
|
Jan 15
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
940
+9.15%
|
-
|
|
Jan 15
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
940
-7.26%
|
-
|
|
Jan 14
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
6,394
+33.06%
|
-
|
|
Jan 14
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
6,394
-4.28%
|
-
|
|
Jan 08
2021
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Open market or private sale
|
Direct |
11,250
-2.51%
|
$787,500
$70.0 P/Share
|
|
Jan 06
2021
|
Brandy Burkhalter EVP |
SELL
Open market or private sale
|
Direct |
8,000
-2.07%
|
$536,000
$67.0 P/Share
|
|
Dec 31
2020
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
491
+2.22%
|
$30,933
$63.53 P/Share
|
|
Dec 31
2020
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
491
+0.15%
|
$30,933
$63.53 P/Share
|
|
Dec 31
2020
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
491
+0.56%
|
$30,933
$63.53 P/Share
|
|
Dec 31
2020
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
668
+0.1%
|
$42,084
$63.53 P/Share
|
|
Dec 31
2020
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
550
+0.26%
|
$34,650
$63.53 P/Share
|
|
Dec 31
2020
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
550
+0.25%
|
$34,650
$63.53 P/Share
|
|
Dec 31
2020
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
491
+0.23%
|
$30,933
$63.53 P/Share
|
|
Dec 19
2020
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,074
-0.24%
|
$65,514
$61.15 P/Share
|
|
Dec 15
2020
|
Christopher R Isaak SVP, Corporate Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,693
-16.5%
|
$158,887
$59.73 P/Share
|
|
Dec 15
2020
|
Christopher R Isaak SVP, Corporate Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,105
+11.42%
|
$103,145
$49.85 P/Share
|
|
Dec 15
2020
|
David P Thomas CEO, Markets and Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+23.45%
|
$1,475,000
$59.73 P/Share
|
|
Dec 15
2020
|
Mark J Brooks EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,555
+8.74%
|
$1,865,970
$54.79 P/Share
|
|
Dec 15
2020
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,224
-7.25%
|
$721,216
$59.73 P/Share
|
|
Dec 15
2020
|
Christopher Koster Secretary & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
45,746
+14.31%
|
$2,470,284
$54.79 P/Share
|
|
Dec 15
2020
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,351
-7.36%
|
$433,709
$59.73 P/Share
|
|
Dec 15
2020
|
Brandy Burkhalter EVP |
BUY
Grant, award, or other acquisition
|
Direct |
87,747
+9.75%
|
$4,738,338
$54.79 P/Share
|
|
Dec 15
2020
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
9,911
-3.12%
|
$584,749
$59.73 P/Share
|
|
Dec 15
2020
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
BUY
Grant, award, or other acquisition
|
Direct |
109,368
+10.23%
|
$5,905,872
$54.79 P/Share
|
|
Dec 15
2020
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
SELL
Payment of exercise price or tax liability
|
Direct |
24,778
-6.05%
|
$1,461,902
$59.73 P/Share
|
|
Dec 15
2020
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
103,558
+10.09%
|
$5,592,132
$54.79 P/Share
|
|
Dec 15
2020
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
17,345
-4.61%
|
$1,023,355
$59.73 P/Share
|
|
Dec 15
2020
|
Michael F Neidorff Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
353,296
+2.62%
|
$19,431,280
$55.08 P/Share
|
|
Dec 15
2020
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
132,145
-2.05%
|
$7,796,555
$59.73 P/Share
|
|
Dec 13
2020
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,092
-0.28%
|
$1,085,520
$60.71 P/Share
|
|
Dec 12
2020
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,767
-1.1%
|
$106,020
$60.71 P/Share
|
|
Dec 12
2020
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,433
-0.46%
|
$85,980
$60.71 P/Share
|
|
Dec 12
2020
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-1.12%
|
$63,780
$60.71 P/Share
|
|
Dec 12
2020
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
SELL
Payment of exercise price or tax liability
|
Direct |
3,581
-0.91%
|
$214,860
$60.71 P/Share
|
|
Dec 12
2020
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,273
-0.24%
|
$916,380
$60.71 P/Share
|
|
Dec 12
2020
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,507
-0.69%
|
$150,420
$60.71 P/Share
|
|
Dec 12
2020
|
Christopher R Isaak SVP, Corporate Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-2.67%
|
$23,400
$60.71 P/Share
|
|
Dec 11
2020
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
1,239
-2.14%
|
$75,579
$61.31 P/Share
|
|
Dec 11
2020
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-1.17%
|
$116,510
$61.31 P/Share
|
|
Dec 11
2020
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
3,581
-1.14%
|
$218,441
$61.31 P/Share
|
|
Dec 11
2020
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-1.24%
|
$72,834
$61.31 P/Share
|
|
Dec 11
2020
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
SELL
Payment of exercise price or tax liability
|
Direct |
5,967
-1.49%
|
$363,987
$61.31 P/Share
|
|
Dec 11
2020
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,014
-0.27%
|
$1,037,854
$61.31 P/Share
|
|
Dec 11
2020
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-0.52%
|
$116,510
$61.31 P/Share
|